Dr. Berardis is director of the Department of Mental Health, ASL 4 Teramo, Italy and collaborates independently with the Institute of Psychiatry of G. d’Annunzio University Chieti-Pescara, Italy.

He is specialized in Cognitive-Behavioral Therapy (CBT) and works also as psychotherapist mainly treating patients with personality disorders and OCD. He is the principal investigator of several research projects, mostly related to alexithymia, anxiety disorders, suicide, schizophrenia, neuroimaging, and clinical psychopharmacology. He has published over 200 articles with impact factor, for an h-index of 52 (7894 citations, Google Scholar, 2022) and 42 (4878 citations, Scopus, 2022), and has frequently participated in national and international congresses as a speaker or through oral or written communications. These papers together with several book chapters reflect his main research lines and areas of recognized expertise on alexithymia, anxiety and mood disorders, functional magnetic resonance and clinical psychopharmacology. He regularly collaborates with professors and researchers from other universities in Italy and other European as well as US and Indian countries.

His professional activities also include the reviewing of scientific manuscripts for high-impact journals and is a member of the Editorial Board of Journal of Clinical Medicine, Brain Sciences, BMC Psychiatry, Depression Research and Treatment, Women, Psychiatry International, Diseases, Current Drug Therapy, Current Drug Discovery Technologies, Current Psychopharmacology, The Open Biology Journal, ISRN Psychiatry, Annals of Depression and Anxiety, International Journal of Clinical Toxicology, Journal of Psychology and Psychotherapy Research, Bipolar Disorder: Open Access, Journal of Neuropsychopharmacology and Mental Health, Journal of Advanced Biomarkers Research and Journal of Sleep Medicine and Disorders.

He is Associate Editor of Research and Advances in Psychiatry and Academic Editor of British Journal of Medicine and Medical Research. He serves also as Review Editor in the field of Neurodegeneration and Addictive Disorders for Frontiers in Neuroscience (IF 3.398), Frontiers in Psychiatry and Frontiers in Neurology (IF 3.184).